[1] KADOWAKI T,YAMAUCHI T.Adiponectin and adiponectin receptors[J].Endocrine Reviews,2005,26(3):439-451.
[2] WAKI H,YAMAUCHI T,KAMON J,et al.Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1[J].Endocrinology,2005,146:790-796.
[3] LAM K S,XU A.Adiponectin:protection of the endothelium[J].Curr Diab Rep,2005,5(4):254-259.
[4] YAMAUCHI T,KAMON J,ITO Y,et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects [J].Nature,2003,423 (6941):762-769.
[5] SHARMA K,RAMACHANDRARAO S,QIU G,et al.Adiponectin regulates albuminuria and podocyte function in mice[J].J Clin Invest,2008(118):1645-1656.
[6] SHEN Y Y,HUGHES J T,CHARLESWORTH J A,et al.Adiponectin is present in the urine in its native conformation,and specifically reduces the secretion of MCP-1 by proximal tubular cells[J].Nephrology,2008,13:405-410.
[7] HUG C,WANG J,AHMAD N S,et al.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin[J].PNAS,2004,101(28):10308-10313.
[8] TAMOTSU T,YOSHIHIRO A,YUJI O,et al.Adiponectin receptors,with special focus on the role of the third receptor,T-cadherin,in vascular disease[J].Med Mol Morphol,2007,40:115-120.
[9] CAMMISOTTO P G,LONDONO I,GINGRAS D,et al.Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats[J].Am J Physiol Renal Physiol,2008,294: F881-F889.
[10] KOJI O,HIROTSUGU I,SHINJI K,et al.Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice[J].Arterioscler Thromb Vasc Biol,2007,27:1910-1917.
[11] TAKEMURA Y,OUCHI N,SHIBATA R,et al.Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies[J].J Clin Invest,2007,117:375-386.
[12] ZOCCALI C,MALLAMACI F,PANUCCIO V,et al.Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors[J].Kidney Int,2003,84(Suppl):S98-102.
[13] BAKKALOGLU S A,SOYLEMEZOGLU O,BUYAN N,et al.High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse[J].Pediatr Nephrol,2005,20(4):474-477.
[14] TAKAHASHI M,OTSUBO S,UCHIDA K,et al.Association between serum adiponectin levels and arteriolosclerosis in IgA nephropathy patients[J].Internal Medicine,2007,46(8):453-459.
[15] LOOKER H C,KRAKOFF J,FUNAHASHI T,et al.Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indian with Type 2 diabetes[J].J Clin Endocrinol Metab,2004,89(8):4010-4017.
[16] LIN L,HU F B,CURHAN G.Serum adiponectin and renal dysfunction in men with type 2 diabetes[J].Diabetes Care,2007,30(2): 239-244.
[17] RISCH L,SAELY C,HOEFLE G,et al.Relationship between glomerular filtration rate and the adipokines adiponectin,resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function[J].Clinica Chimica Acta,2007,376:108-113.
[18] KATO K,OSAVA H,OCHI M,et al.Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy[J].Clinical Endocrinology,2008,68:442-449.
[19] KOMABA H,IGAKI N,GOTO S,et al.Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function[J].Am J Nephrol,2006,26(5):476-482.
[20] KOSHIMURA J,FUJITA H,NATITA T,et al.Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy[J].Biochem Biophys Res Commun,2004,316 (1):165-169.
[21] FUJITA H,MORII T,KOSHIMURA J,et al.Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy[J].Endocr J,2006,53 (6):745-752.
[22] HADJADJ S,AUBERT R,FUMERON F,et al.Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects[J].Diabetologia,2005,48(6):1088-1092.
[23] SARAHEIMO M,FORSBLOM C,THORN L,et al.Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes[J].Diabetes Care,2008,31(6):1165-1169.
[24] SCHALKWIJK C G,CHATURVEDI N,SCHRAM M T,et al.Adiponectin is inversely associated with renal function in type 1 diabetic patients [J].J Clin Endocrinol Metab,2006,91(1):129-135.
[25] SARAHEIMO M,FORSBLOM C,FAGERUDD J,et al.Serum adiponectin is increased in type 1 diabetic patients with nephropathy[J].Diabetes Care,2005,28 (6):1410-1414.
[26] RYUICHI F,MARI O,HIROMICHI K.Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients[J].Nephrol Dial Transplant,2006,21:494-498.
[27] TAKEGUCHI F,NAKAYAMA M,NAKAO T.Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis[J].Therapeutic Apheresis and Dialysis,2008,12(3):243-249.
[28] BAKKALOGLU S A,BUYAN N,FUNAHASHI T,et al.Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients[J].Perit Dial Int,2005,25(4):357-361.
[29] IGNACY W,CHUDEK J,ADAMCZAK M,et al.Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease-a follow-up study[J].J Nephron,2005,101(1):c18-24.
[30] ZOCCALI C,MALLAMACI F,TRIPEPI G,et al.Adiponectin,metabolic risk factor,and cardiovascular events among patients with end-stage renal disease[J].J Am Soc Nephrol,2002,13(1):134-141.
[31] OHASHI N,KATO A,MISAKI T,et al.Association of serum adiponectin levels with all-cause mortality in hemodialysis patients[J].Inter Med,2008,(47):485-491.
[32] DEKKER J M,FUNAHASHI T,NIJPEL G,et al.Prognostic value of adiponectin for cardiovascular disease and mortality[J].J Clin Endocrinol Metab,2008,93(4):1489-1496.